Finally, we associate STAT3 and CREB expression status with AR signaling and ADT resistance in PCa patients, supporting the hypothesis that these are critical regulators and therapeutic targets in metastatic PCa. This evidence concerns the gene CREB1 and posterior cortical atrophy.